Evidence map›Paper›PMID 31350570›Full record

ReviewPlant cell reports2019

Genetic modification in Malaysia and India: current regulatory framework and the special case of non-transformative RNAi in agriculture.

Jasdeep Kaur Darsan Singh, Nurzatil Sharleeza Mat Jalaluddin, Neeti Sanan-Mishra, Jennifer Ann Harikrishna

Abstract readReview
PubMed Publisher
In one paragraph

Review in Plant cell reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. RNA Structure: Past, Future, and Gene Therapy Applications.International journal of molecular sciences · 2024
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jasdeep Kaur Darsan SinghCentre for Research in Biotechnology for Agriculture (CEBAR), Level 3, Research Management and Innovation Complex, University of Malaya, Jalan Universiti, 50603, Kuala Lumpur, Malaysia.
Nurzatil Sharleeza Mat JalaluddinCentre for Research in Biotechnology for Agriculture (CEBAR), Level 3, Research Management and Innovation Complex, University of Malaya, Jalan Universiti, 50603, Kuala Lumpur, Malaysia.
Neeti Sanan-MishraInternational Centre for Genetic Engineering and Biotechnology (ICGEB), Aruna Asaf Ali Marg, New Delhi, Delhi, 110067, India.
Jennifer Ann HarikrishnaCentre for Research in Biotechnology for Agriculture (CEBAR), Level 3, Research Management and Innovation Complex, University of Malaya, Jalan Universiti, 50603, Kuala Lumpur, Malaysia. jennihari@um.edu.my.

Funding

Ministry of Education Malaysia RU006-2017Ministry of Education Malaysia RU006-2018 (University of Malaya)Ministry of Education, Malaysia MyPhD scholarship under MyBrain 15 ProgrammeUniversity of Malaya Postdoctoral Research Fellowship Scheme
6 · The paper itself

Abstract

Recent developments in modern biotechnology such as the use of RNA interference (RNAi) have broadened the scope of crop genetic modification. RNAi strategies have led to significant achievements in crop protection against biotic and abiotic stresses, modification of plant traits, and yield improvement. As RNAi-derived varieties of crops become more useful in the field, it is important to examine the capacity of current regulatory systems to deal with such varieties, and to determine if changes are needed to improve the existing frameworks. We review the biosafety frameworks from the perspective of developing countries that are increasingly involved in modern biotechnology research, including RNAi applications, and make some recommendations. Malaysia and India have approved laws regulating living modified organisms and products thereof, highlighting that the use of any genetically modified step requires regulatory scrutiny. In view of production methods for exogenously applied double-stranded RNAs and potential risks from the resulting double-stranded RNA-based products, we argue that a process-based system may be inappropriate for the non-transformative RNAi technology. We here propose that the current legislation needs rewording to take account of the non-transgenic RNAi technology, and discuss the best alternative for regulatory systems in India and Malaysia in comparison with the existing frameworks in other countries.

Indexed as

AgricultureBiotechnologyCrops, AgriculturalIndiaMalaysiaPlants, Genetically ModifiedRisk AssessmentRNA InterferenceGene silencingNon-transformative RNAiRegulationRisk assessmentRNAi-based biopesticidesRNA interference

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.